Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
International Journal of Hematology|October 27, 2025
Novel noninvasive parameters for diagnosis of liver involvement in patients with systemic AL amyloidosisRyohei Sumitani, Hirokazu Miki, Shingen Nakamura, et al.
Research Square|July 18, 2025
Development of a rapid and novel diagnostic technique for cardiac amyloidosis using Raman spectroscopyMizuki Yoshimoto, Shin-Ichiro Yanagiya, Hiroki Takanari, et al.
International Journal of Hematology|April 11, 2023
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitorsEmiko Nakaue, Jumpei Teramachi, Hirofumi Tenshin, et al.
Molecular Cancer Therapeutics|January 17, 2019
Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor GrowthTakeshi Harada, Shinji Matsumoto, Suguru Hirota, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 8, 2017
[Analysis of long-term survivors with cardiac AL amyloidosis]Kumiko Kagawa, Yusaku Maeda, Masahiro Oura, et al.
British Journal of Haematology|September 10, 2011
KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclastsHirokazu Miki, Shuji Ozaki, Shingen Nakamura, et al.
Blood Advances|April 2, 2026
IL-6-driven POU2AF1 and ELL2 are key regulators of multiple myeloma-distinct transcriptional and splicing programsYasuyo Ohguchi, Masahiko Ajiro, Daisuke Ogiya, et al.
Pageof 12